The global auto-injectors market is expected to register substantial growth over the next few years. The prominent factors driving the progress of the market are the increasing incidence of anaphylaxis and the soaring healthcare expenditure in several countries. In addition to this, the advent of various biologic drug therapies and minimized needle-stick injuries and the increasing geriatric population are the other important factors propelling the market advancement across the world. 

Browse In-depth Auto-Injectors Market Research Report@ https://www.psmarketresearch.com/market-analysis/auto-injectors-market

Needle-stick injuries during drug administration can cause blood-borne pathogen transmission, which can, in turn, lead to fear, emotional distress, and anxiety among healthcare workers. These risks associated with the usage of needle-sticks are greatly reduced by using auto-injectors. As per the World Health Organization (WHO), around 16 billion injections are administered across the globe every year. The organization also found that unsafe injections cause nearly 1.3 million deaths around the world every year. 

Besides the aforementioned factors, the increasing prevalence of diabetes is also propelling the advancement of the auto-injectors market across the globe. As per the WHO, 422 million adults all over the globe were diagnosed with diabetes in 2014. The mushrooming prevalence of diabetes is causing a sharp surge in the demand for auto-injectors. These devices are widely used for the home-based treatment of major diseases such as rheumatoid arthritis, anaphylaxis, and multiple sclerosis.

Geographically, the auto-injectors market is currently recording the highest growth in North America, as per the findings of P&S Intelligence, a market research firm based in India. In this region, the market is exhibiting the highest growth in the U.S. The prominent factors fueling the expansion of the market in this region are the rising prevalence of anaphylaxis and diabetes, the surging geriatric population, and the rapid production of biologics.

Thus, it is safe to say that the market would demonstrate rapid advancement throughout the world in the upcoming years, primarily because of the growing incidence of diabetes and other chronic diseases, the surging geriatric population in several countries, and the ballooning demand for better and safer drug administering devices around the world.